Skip to main content
. 2021 Mar 5;70(6):1404–1413. doi: 10.2337/db20-1167

Table 3.

Associations between GrimAge measurements at Y15–Y20 and incident T2D during Y15–Y25 by BMI status at Y15

Normal weight at Y15 (BMI <25 kg/m2, N = 345) Overweight at Y15 (BMI 25–30 kg/m2, N = 394) With obesity at Y15 (BMI ≥30 kg/m2, N = 318) Pinteraction
Model 1: diabetes vs. prediabetes and normal glucose
 Chronological age 1.28 (1.05–1.57)* 1.06 (0.92–1.22) 1.04 (0.95–1.14) 0.29
 GrimAge 1.09 (0.98–1.20) 1.04 (0.98–1.10) 1.06 (1.01–1.11)* 0.19
 GrimAA 1.02 (0.89–1.16) 1.04 (0.97–1.10) 1.08 (1.00–1.15)* 0.30
 Positive GrimAA 2.12 (0.58–7.72) 0.79 (0.44–1.43) 2.57 (1.61–4.11)*** 0.94
 Positive 5yr GrimAA 0.58 (0.17–1.94) 0.42 (0.14–1.27) 1.83 (1.17–2.85)*** <0.01
Model 2: diabetes vs. normal glucose (prediabetes excluded)
 Chronological age 1.40 (1.11–1.76)** 1.06 (0.91–1.24) 1.14 (1.03–1.27)* 0.29
 GrimAge 1.09 (0.98–1.20) 1.03 (0.96–1.10) 1.08 (1.03–1.14)** 0.58
 GrimAA 1.00 (0.88–1.14) 1.02 (0.95–1.11) 1.05 (0.98–1.13) 0.38
 Positive GrimAA 2.14 (0.56–8.24) 0.63 (0.32–1.48) 2.49 (1.44–4.31)** 0.94
 Positive 5yr GrimAA 0.46 (0.13–1.56) 0.38 (0.10–0.89)* 2.35 (1.40–3.94)** <0.01
Model 3: hyperglycemia (diabetes or prediabetes) vs. normal glucose
 Chronological age 1.15 (1.08–1.22)** 1.06 (1.00–1.13) 1.17 (1.09–1.26)*** 0.09
 GrimAge 1.07 (1.02–1.11)** 1.03 (0.99–1.06) 1.06 (1.02–1.10)** 0.72
 GrimAA 1.03 (0.98–1.08) 1.03 (0.98–1.07) 1.00 (0.95–1.05) 0.29
 Positive GrimAA 2.15 (1.35–3.42)** 0.94 (0.66–1.35) 1.15 (0.80–1.67) 0.04
 Positive 5yr GrimAA 1.20 (0.82–1.76) 1.05 (0.77–1.43) 1.90 (1.31–2.76)*** 0.08

Data are OR (95% CI). Models are adjusted for race, sex, education, smoking status, physical activity, alcohol drinking, and field center.

For GrimAge and GrimAA, the ORs and 95% CIs were calculated based on 1-year increase of each measurement.

*

P < 0.05;

**

P < 0.01;

***

P < 0.001.